Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 3/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.60 |
| ▸ | PKM | P14618 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | HPGD | P15428 | 3/20 | 0.53 |
| ▸ | TP53 | P04637 | 2/20 | 0.53 |
| ▸ | RXRA | P19793 | 1/20 | 0.53 |
| ▸ | RXRB | P28702 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 3/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | MITF | O75030 | 1/20 | 0.49 |
| ▸ | XBP1 | P17861 | 1/20 | 0.49 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.49 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.49 |
| ▸ | RELA | Q04206 | 1/20 | 0.49 |
| ▸ | DRD2 | P14416 | 1/20 | 0.49 |
| ▸ | DRD4 | P21917 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3161189 | 0.91 | MEN1 (0.58) | LMNAMEN1KMT2APKMSMN1; SMN2 | |
| SCHEMBL3168428 | 0.89 | MEN1 (0.57) | LMNAMEN1KMT2APKMSMN1; SMN2 | |
| SCHEMBL9322243 | 0.88 | MEN1 (0.55) | LMNAMEN1KMT2APKMSMN1; SMN2 | |
| SCHEMBL9860833 | 0.87 | MEN1 (0.58) | LMNAMEN1KMT2APKMSMN1; SMN2 | |
| SCHEMBL1694563 | 0.86 | LMNA (0.56) | LMNAMEN1KMT2APKMSMN1; SMN2 | |
| SCHEMBL11488532 | 0.84 | MEN1 (0.58) | LMNAMEN1KMT2APKMSMN1; SMN2 | |
| SCHEMBL9001338 | 0.83 | MEN1 (0.54) | LMNAMEN1KMT2APKMSMN1; SMN2 | |
| SCHEMBL31107962 | 0.83 | LMNA (0.53) | LMNAMEN1KMT2APKMSMN1; SMN2 | |
| SCHEMBL21156896 | 0.83 | LMNA (0.53) | LMNAMEN1KMT2APKMSMN1; SMN2 | |
| SCHEMBL101520 | 0.81 | PTGDR2 (0.68) | MEN1KMT2ASMN1; SMN2HPGDTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102438450-A | fruit thinning agent | TAMINCO NV | 2012-05-02 | — | — | CN | claimed |
| US-20120088668-A1 | THINNING AGENT | TAMINCO, NAAMLOZE VENNOOTSCHAP (BE) | 2012-04-12 | — | — | US | claimed |
| EP-2416649-A2 | THINNING AGENT | Taminco, Naamloze Venootschap (BE) | 2012-02-15 | — | — | EP | claimed |
| WO-2010116256-A2 | THINNING AGENT | TAMINCO, NAAMLOZE VENNOOTSCHAP (BE) | 2010-10-14 | — | — | WO | claimed |
| US-20260144795-A1 | SPIROMACROCYCLIC OREXIN 2 RECEPTOR AGONISTS | H. LUNDBECK A/S (DK) | 2026-05-28 | — | — | US | disclosed |
| CN-106061267-B | Application of chemical agent in stone fruit flower thinning | 精细农用化学品有限公司 | 2022-02-01 | — | — | CN | disclosed |
| EP-3091836-B1 | USE OF A CHEMICAL AGENT FOR THINNING OF STONE FRUIT | FINE AGROCHEMICALS LTD (GB) | 2020-05-27 | — | — | EP | disclosed |
| EP-3636807-A1 | CYCLIC PEPTIDE COMPOUND HAVING HIGH MEMBRANE PERMEABILITY, AND LIBRARY CONTAINING SAME | Chugai Seiyaku Kabushiki Kaisha (JP) | 2020-04-15 | — | — | EP | disclosed |
| US-20160330961-A1 | USE OF A CHEMICAL AGENT FOR THINNING OF STONE FRUIT | FINE AGROCHEMICALS LIMITED (GB) | 2016-11-17 | — | — | US | disclosed |
| EP-3091836-A1 | USE OF A CHEMICAL AGENT FOR THINNING OF STONE FRUIT | Fine Agrochemicals Limited (GB) | 2016-11-16 | — | — | EP | disclosed |
| WO-2015104344-A1 | USE OF A CHEMICAL AGENT FOR THINNING OF STONE FRUIT | FINE AGROCHEMICALS LIMITED (GB) | 2015-07-16 | — | — | WO | disclosed |
| EP-2893809-A1 | Use of a chemical agent for thinning of stone fruit | Fine Agrochemicals Limited (GB) | 2015-07-15 | — | — | EP | disclosed |
| WO-2011070131-A1 | 5-AMINO- 4-HYDROXYPENTOYL AMIDES | TIBOTEC PHARMACEUTICALS (IE) | 2011-06-16 | — | — | WO | disclosed |
| WO-2010116256-A2 | THINNING AGENT | TAMINCO, NAAMLOZE VENNOOTSCHAP (BE) | 2010-10-14 | — | — | WO | disclosed |
| US-20100062970-A1 | SYNTHESIS OF PROPYL PHENOXY ETHERS AND USE AS DELIVERY AGENTS | EMISPHERE TECHNOLOGIES INC. (US) | 2010-03-11 | — | — | US | disclosed |
| US-20100062970-A1 | SYNTHESIS OF PROPYL PHENOXY ETHERS AND USE AS DELIVERY AGENTS | EMISPHERE TECHNOLOGIES INC. (US) | 2010-03-11 | — | — | US | disclosed |
| US-20100062970-A1 | SYNTHESIS OF PROPYL PHENOXY ETHERS AND USE AS DELIVERY AGENTS | EMISPHERE TECHNOLOGIES INC. (US) | 2010-03-11 | — | — | US | disclosed |
| EP-2053918-A2 | SYNTHESIS OF PROPYL PHENOXY ETHERS AND USE AS DELIVERY AGENTS | Emisphere Technologies, Inc. (US) | 2009-05-06 | — | — | EP | disclosed |
| WO-2008022242-A2 | SYNTHESIS OF PROPYL PHENOXY ETHERS AND USE AS DELIVERY AGENTS | EMISPHERE TECHNOLOGIES, INC. (US) | 2008-02-21 | — | — | WO | disclosed |
| EP-0087858-A1 | New chromanone compounds and pharmaceutical compositions containing them | NIPPON ZOKI PHARMACEUTICAL CO. LTD. (JP) | 1983-09-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100062970-A1 | SYNTHESIS OF PROPYL PHENOXY ETHERS AND USE AS DELIVERY AGENTS | EPX, HPD, CYP2C8 | LMNA 2327/4885MEN1 3039/4885KMT2A 2202/4885 |
| US-20260144795-A1 | SPIROMACROCYCLIC OREXIN 2 RECEPTOR AGONISTS | HCRTR2, HCRTR1, CRHR1 | LMNA 1231/4885MEN1 2106/4885KMT2A 2095/4885 |
| US-20120088668-A1 | THINNING AGENT | NAT1, MAP2, AANAT | LMNA 1560/4885MEN1 3321/4885KMT2A 3903/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.